首页> 外文OA文献 >Addition of docetaxel or bisphosphonates to standard of care in men with localised or metastatic, hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggregate data

【2h】

Addition of docetaxel or bisphosphonates to standard of care in men with localised or metastatic, hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggregate data

机译：在患有局限性或转移性，激素敏感性前列腺癌的男性中，将多西他赛或双膦酸盐添加到护理标准中：汇总数据的系统评价和荟萃分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Vale, Claire L.; Burdett, Sarah; Rydzewska, Larysa H. M.; Albiges, Laurence; Clarke, Noel W.; Fisher, David; Fizazi, Karim; Gravis, Gwenaelle; James, Nicholas D.; Mason, Malcolm David; Parmar, Mahesh K. B.; Sweeney, Christopher J.; Sydes, Matthew R.; Tombal, Bertrand; Tierney, Jayne F.;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Addition of docetaxel or bisphosphonates to standard of care in men with localised or metastatic, hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggregate data (vol 17, pg 243, 2016) [J] . Vale C. L., Burdett S., Rydzewska L. H. M. The lancet oncology . 2016,第2期

机译：在患有局限性或转移性，激素敏感性前列腺癌的男性中，将多西他赛或双膦酸盐添加到治疗标准中：汇总数据的系统评价和荟萃分析（第17卷，第243页，2016年）
2. Addition of docetaxel or bisphosphonates to standard of care in men with localised or metastatic, hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggregate data [J] . Vale Claire L., Burdett Sarah, Rydzewska Larysa H. M., The lancet oncology . 2016,第2期

机译：在患有局部或转移性，激素敏感性前列腺癌的男性中，将多西他赛或双膦酸盐添加到治疗标准中：汇总数据的系统评价和荟萃分析
3. Addition of Docetaxel to Androgen Deprivation Therapy for Patients with Hormone-sensitive Metastatic Prostate Cancer: A Systematic Review and Meta-analysis [J] . Tucci Marcello, Bertaglia Valentina, Vignani Francesca, European urology . 2016,第4期

机译：多西他赛在激素敏感性转移性前列腺癌患者的雄激素剥夺治疗中的应用：系统评价和荟萃分析
4. Metastatic Hormone-Sensitive and Castration-Resistant Prostate Cancer: A Decade of Progress and Ongoing Discoveries [C] . Leonel Hernez-Aya, Maha Hussain Genitourinary Cancers Symposium. . 2014

机译：转移激素敏感和阉割的前列腺癌：进步和持续发现的十年
5. Cost and Management of Fractures in Medicare Beneficiaries with Non-Metastatic Prostate Cancer Treated with Androgen Deprivation Therapy. [D] . Yong, Candice Yuk Chen. 2015

机译：用雄激素剥夺疗法治疗的非转移性前列腺癌医疗保险受益人骨折的成本和管理。
6. Addition of docetaxel or bisphosphonates to standard of care in men with localised or metastatic hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggregate data [O] . Claire L Vale, Sarah Burdett, Larysa H M Rydzewska, -1

机译：在患有局部或转移性激素敏感性前列腺癌的男性中将多西他赛或双膦酸盐添加到治疗标准中：汇总数据的系统评价和荟萃分析
7. Addition of docetaxel or bisphosphonates to standard of care in men with localised or metastatic, hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggregate data [O] . Vale C., Burdett S., Rydzewska L., 2016

机译：在局部或转移性，激素敏感的前列腺癌患者中加入多西紫杉醇或双膦酸盐治疗标准治疗：对总体数据的系统评价和荟萃分析

Addition of docetaxel or bisphosphonates to standard of care in men with localised or metastatic, hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggregate data

著录项

相似文献

相关主题

期刊订阅